FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

WANBURY Share Price Discussion

Wanbury Ltd.
Sector: Pharmaceuticals and health care
... Read more
WANBURY Long Term Analysts Rating
0/5 (0 Ratings)
WANBURY Share Price *
0 +0 (0%)
* (quote may be delayed)

Find answers to all your questions on live WANBURY message board: Is WANBURY buy or sell? Should I buy WANBURY shares? Why are WANBURY shares falling? Should I invest in WANBURY stock?


WANBURY Discussion Forum

hourglass_empty
No posts yet.
This service may be new or inactive. Please check back later.
  • WANBURY - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization73.53
    Enterprise Value291.35
    Price to Earnings38.85
    Price to Book Value0.53
    Return on Capital Employed-0.02
    Return on Equity0.2
    Face Value10
    Dividend YieldNA
  • WANBURY - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue372436.63-0.15
    Operating Profit-6718.86-4.55
    Profit Before Tax-32-4.615.94
    Net Income-32-5.055.34
  • WANBURY - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds-159-189.58-0.16
    Total Liabilities430606.32-0.29
    Total Assets270416.74-0.35
  • WANBURY - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity3243.39-0.26
    Cash from Investing Activity-1-13.53-0.93
    Cash from Financing Activity-33-26.470.25
    Net Cash Flow-23.4-1.59
  • WANBURY - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.12-0.01
    Return on Equity0.20.03
    Return on Capital Employed-0.020.09
  • WANBURY - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.49
    3 Year CAGR Growth in Operating Profit-4.13
    3 Year CAGR Growth in EBIDTA1.14
    3 Year CAGR Growth in Net Income-10.97
    3 Yr CAGR Growth - Diluted EPS-9.38
  • WANBURY - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.1
    5 Year CAGR Growth in Operating Profit-5.2
    5 Year CAGR Growth in EBIDTA0.02
    5 Year CAGR Growth in Net Income-0.26
    3 Yr CAGR Growth - Diluted EPS0.08
  • WANBURY - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
    Divi's Laboratories Ltd. Sector: Pha...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.